Oncogene
Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. Oncogene propagates work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far. Areas covered by Oncogene include, but are not limited to, the cellular and molecular biology of cancer including resistance to cancer therapies, and development of better approaches to improving survival. Across cancer biology, we have a broad remit encompassing the life sciences and biomedicine, from the most fundamental and theoretical work, through to translational, applied, and clinical research.
http://feeds.nature.com/onc/rss/current
Nature Publishing Group
en
© 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Oncogene
© 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
permissions@nature.com
Oncogene
https://www.nature.com/uploads/product/onc/rss.gif
http://feeds.nature.com/onc/rss/current
-
https://www.nature.com/articles/s41388-024-03013-4
Oncogene, Published online: 28 March 2024; doi:10.1038/s41388-024-03013-4Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma]]>
Shengpan WuBaojun WangHongzhao LiHanfeng WangSongliang DuXing HuangYang FanYu GaoLiangyou GuQingbo HuangJianjun ChenXu ZhangYan HuangXin Ma
doi:10.1038/s41388-024-03013-4
Oncogene, Published online: 2024-03-28; | doi:10.1038/s41388-024-03013-4
2024-03-28
Oncogene
10.1038/s41388-024-03013-4
https://www.nature.com/articles/s41388-024-03013-4
-
https://www.nature.com/articles/s41388-024-02944-2
Oncogene, Published online: 26 March 2024; doi:10.1038/s41388-024-02944-2SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain]]>
Qianhui YiXiaojun HanHenry G. YuHuei-Yu ChenDinghong QiuJie SuRongtuan LinGerald BatistJian Hui Wu
doi:10.1038/s41388-024-02944-2
Oncogene, Published online: 2024-03-26; | doi:10.1038/s41388-024-02944-2
2024-03-26
Oncogene
10.1038/s41388-024-02944-2
https://www.nature.com/articles/s41388-024-02944-2
-
https://www.nature.com/articles/s41388-024-03008-1
Oncogene, Published online: 22 March 2024; doi:10.1038/s41388-024-03008-1Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour metastasis]]>
Xue LiYulin ChenRan LuMin HuLei GuQiaorong HuangWentong MengHongyan ZhuChuanwen FanZongguang ZhouXianming Mo
doi:10.1038/s41388-024-03008-1
Oncogene, Published online: 2024-03-22; | doi:10.1038/s41388-024-03008-1
2024-03-22
Oncogene
10.1038/s41388-024-03008-1
https://www.nature.com/articles/s41388-024-03008-1
-
https://www.nature.com/articles/s41388-024-03010-7
Oncogene, Published online: 22 March 2024; doi:10.1038/s41388-024-03010-7ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions]]>
Simon DurandYaqi TangRoxane M. PommierValentin BenboubkerMaxime GrimontFelix BoivinLaetitia Barbollat-BoutrandEric CumunelFlorian DupeubleAnaïs EberhardtMaud PlaschkaStéphane DalleJulie Caramel
doi:10.1038/s41388-024-03010-7
Oncogene, Published online: 2024-03-22; | doi:10.1038/s41388-024-03010-7
2024-03-22
Oncogene
10.1038/s41388-024-03010-7
https://www.nature.com/articles/s41388-024-03010-7
-
https://www.nature.com/articles/s41388-024-03006-3
Oncogene, Published online: 21 March 2024; doi:10.1038/s41388-024-03006-3Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1]]>
Tengxiao GuoYuxia WangXiaolu SunShuaibing HouYanjie LanShengnan YuanShuang YangFei ZhaoYajing ChuYuanwu MaTao ChengJia YuBing LiuWeiping YuanXiaomin Wang
doi:10.1038/s41388-024-03006-3
Oncogene, Published online: 2024-03-21; | doi:10.1038/s41388-024-03006-3
2024-03-21
Oncogene
10.1038/s41388-024-03006-3
https://www.nature.com/articles/s41388-024-03006-3
-
https://www.nature.com/articles/s41388-024-02949-x
Oncogene, Published online: 21 March 2024; doi:10.1038/s41388-024-02949-xRNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis]]>
Wanqun XieJiajia WangShuaiwei TianHeng ZhaoLiangliang CaoZhuangzhuang LiangJian YangYang ZhaoBaocheng WangFeng JiangJie Ma
doi:10.1038/s41388-024-02949-x
Oncogene, Published online: 2024-03-21; | doi:10.1038/s41388-024-02949-x
2024-03-21
Oncogene
10.1038/s41388-024-02949-x
https://www.nature.com/articles/s41388-024-02949-x
-
https://www.nature.com/articles/s41388-024-03007-2
Oncogene, Published online: 20 March 2024; doi:10.1038/s41388-024-03007-2E-cadherin interacts with EGFR resulting in hyper-activation of ERK in multiple models of breast cancer]]>
Gabriella C. RussoAshleigh J. CrawfordDavid ClarkJulie CuiRyan CarneyMichelle N. KarlBoyang SuBartholomew StarichTung-Shing LihPratik KamatQiming ZhangPraful R. NairPei-Hsun WuMeng-Horng LeeHon S. LeongHui ZhangVito W. RebeccaDenis Wirtz
doi:10.1038/s41388-024-03007-2
Oncogene, Published online: 2024-03-20; | doi:10.1038/s41388-024-03007-2
2024-03-20
Oncogene
10.1038/s41388-024-03007-2
https://www.nature.com/articles/s41388-024-03007-2
-
https://www.nature.com/articles/s41388-024-03005-4
Oncogene, Published online: 13 March 2024; doi:10.1038/s41388-024-03005-4DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer]]>
Shaoqiang GuoMiaomiao MiaoYufeng WuDongyue PanQinyan WuZhanfang KangJianwen ZengGuoping ZhongChengfei LiuJunjian Wang
doi:10.1038/s41388-024-03005-4
Oncogene, Published online: 2024-03-13; | doi:10.1038/s41388-024-03005-4
2024-03-13
Oncogene
10.1038/s41388-024-03005-4
https://www.nature.com/articles/s41388-024-03005-4